The combined clinicopathological factors and gene-expression profile (CP-GEP) test can identify which patients with primary ...

MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...

For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 ...

A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma ...

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk ...

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph ...

From blood tests that predict recurrence to smarter, less invasive treatments, 2025 is delivering real hope—especially for ...

Is the removal of lymph nodes - tiny, bean-shaped nodules that filter waste and bacteria - really the best way to prevent ...

Penile squamous cell carcinoma (SCC) is a rare malignancy where accurate nodal staging is essential for prognosis and management. Dynamic sentinel lymph node biopsy with radiotracers is the standard ...

Department of Breast Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. Breast cancer is the most common malignant tumor among women worldwide. There were 2.26 million new ...

ABSTRACT: Breast cancer is one of the most common malignant tumors in women worldwide, posing a serious threat to women’s health. The incidence of breast cancer is on the rise, and the proportion of ...